Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trialMwayiwawo Madanitsa, Feiko O. ter Kuile, Omari Abdul Msemo et al.|The Lancet|2023Cited by 72
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trialHellen C. Barsosio, Feiko O. ter Kuile, Mwayiwawo Madanitsa et al.|The Lancet|2024Cited by 21
Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysisMichelle E. Roh, Feiko O. ter Kuile, Julie Gutman et al.|EClinicalMedicine|2025Cited by 17
Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trialSilke Fernandes, Kara Hanson, Halimatou Diawara et al.|Malaria Journal|2016Cited by 16
Improving birth weight measurement and recording practices in Kenya and Tanzania: a prospective intervention study with historical controlsAlloys K’Oloo, Pieta Näsänen‐Gilmore, Evance Godfrey et al.|Population Health Metrics|2023Cited by 10